Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.4171
-7.06 %
$ 12.5 M
Market Cap
-0.27
P/E
PRPH - CAPITAL EXPENDITURES
Capital Expenditures PRPH - ProPhase Labs, Inc.
-3.16 M
LAST VALUE
13.65%
2 YEAR CAGR
-86.46%
5 YEAR CAGR
-21.72%
10 YEAR CAGR